Medication in the Management of Sleep Disorders in Children with ADHD and ASD: A Bibliographic Analysis

• DOI: https://doi.org/10.22533/at.ed.1595282506082

• Palavras-chave: ADHD, ASD, Sleep Disorders, Pharmacotherapy, Children, Methylphenidate, Atomoxetine, Melatonin, Risperidone.

• Keywords: ADHD, ASD, Sleep Disorders, Pharmacotherapy, Children, Methylphenidate, Atomoxetine, Melatonin, Risperidone.

• Abstract:

  Sleep is a fundamental pillar for neurological and cognitive development in children. In children with Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD), sleep dysregulation is a frequent and debilitating comorbidity, manifesting as restless, fragmented and non-restorative sleep. This dysregulation directly impacts daytime functioning, exacerbating the core symptoms of ADHD and ASD. This article explores drug intervention as an auxiliary tool in the management of these sleep difficulties, analyzing the main drugs used, their mechanisms of action in the brain and the evidence of their efficacy and safety in pediatric populations with ADHD and ASD. The bibliographic analysis seeks to provide an in-depth understanding of how medication can contribute to improving sleep quality and, consequently, the quality of life of these children.